Fig. 2

HOXD9 is upregulated in gastric cancer tissues and associated with poor prognosis. a TMA representative images of IHC staining of HOXD9 in GC tissue. a Negative HOXD9 expression; (b) weak HOXD9 expression; (c) moderate HOXD9 expression; (d) strong HOXD9 expression in GC. Scale bars, 50 mm in A. Kaplan–Meier survival analysis of overall survival in all patients (b), the patients at the early stage of GC (c) and the patients at the late stage of GC (d) according to HOXD9 expression. The log-rank test was used to calculate P-values